Fosun Worldwide Earns a Spot on “2024 Fortune China ESG Affect Listing” By Investing.com

HONG KONG, Might 15, 2024 /PRNewswire/ — On 13 Might 2024, Fortune China journal launched the 2024 China ESG Affect Listing, and Fosun Worldwide Restricted (“Fosun Worldwide” or the “Firm”) (HKEX inventory code: 00656) was included within the listing, highlighting its excellent efficiency and trade management within the areas of environmental, social and governance (ESG).

Fortune China identified that since 2023, ESG practices in China have been steadily advancing. In a yr of extreme macroeconomic challenges, ESG has turn into a guideline for firms to boost their long-term competitiveness. The 2024 China ESG Affect Listing launched by Fortune  China options 101 firms. This yr, Fortune China  opened the applying to international firms working in China for the primary time, with 31 international firms efficiently making it to the listing. These firms are broadly represented in varied sectors similar to new vitality, Web, finance, well being, and manufacturing, and maintain important affect inside their respective industries. Along with Fosun Worldwide, different firms on the listing embrace Alibaba (NYSE:), Ant Group, JD (NASDAQ:).com, Lenovo, Xiaomi (OTC:), Financial institution of China, China Pacific Insurance coverage, New World China, Shui On Land, CNOOC (NYSE:), Citibank, Microsoft (NASDAQ:), Siemens, Yum China, Pepsi, and extra.

Fortune China journal said that the chosen firms are main firms that may have a constructive influence in China’s enterprise setting. Fosun Worldwide has made excellent efforts in bettering the setting, defending workers, and supporting communities. It has additionally demonstrated sustained and inclusive development all through financial cycles and gained market respect, thus efficiently making it to the listing.

Actively selling world sustainable improvement, reaching excellent ESG score

This yr marks the tenth anniversary of Fosun Worldwide’s becoming a member of the United Nations International Compact (“UN International Compact“). Since becoming a member of the UN International Compact, Fosun has built-in the ten rules of the UN International Compact on human rights, labor, setting and anti-corruption into its company technique and operations to make sure accountable enterprise practices. Fosun Worldwide has additionally actively engaged its member firms within the implementation of ESG methods.

Regardless of the macro setting stays difficult within the post-pandemic period, Fosun has made important progress in fulfilling its unwavering dedication to sustainable improvement. In 2023, Fosun Worldwide  obtained an MSCI ESG score of AA for 3 consecutive years, and was the one conglomerate in Larger China with such score. Fosun Worldwide’s HSI ESG score was upgraded to AA- and it was chosen as one of many constituents of Company Sustainability Index for the primary time. As well as, Fosun ranked among the many prime 6% amongst world friends within the S&P International Company Sustainability Evaluation (CSA) and was included in S&P International’s Sustainability Yearbook 2024 and acknowledged as an “Business Mover” for its excellent efficiency. Fosun has additionally been chosen as a constituent of the FTSE4Good Index Sequence for 2 consecutive years.

Leveraging innovation to actively contribute to society

Fosun adheres to the innovation-driven technique and actively facilitates its companies to realize modern outcomes in order to make larger contributions to society. In 2023, Fosun made new breakthroughs in anticancer and antimalarial medication, which profit sufferers with most cancers and extreme malaria sufferers. HANSIZHUANG (Serplulimab Injection), the world’s first anti-PD-1 monoclonal antibody accepted for first-line therapy of extensive-stage small cell lung most cancers (SCLC) independently developed by Shanghai Henlius has been accepted for 4 indications. The second-generation artesunate for injection (Argesun ®) was prequalified by the World Well being Group (WHO-PQ), changing into the primary injectable artesunate offered with a single solvent system accepted by WHO-PQ, drastically bettering the comfort of scientific use. As of the top of 2023, artesunate for injection has saved over 68 million extreme malaria sufferers worldwide. China’s first CAR-T cell remedy product, Yi Kai Da (Ejilunsai Injection), developed by Fosun Kite, has obtained conditional approval from the Nationwide Medical Merchandise Administration (NMPA) for a brand new second-line indication, bringing extra therapy choices and hope for Chinese language lymphoma sufferers.

Wanting forward, Fosun will proceed to maintain abreast of the event of the worldwide sustainable improvement subject, refine and improve Fosun’s ESG administration, actively reply to nationwide methods, guarantee info safety, promote expertise innovation, implement “twin carbon” targets, take part in philanthropy, and shield the rights and pursuits of workers to advertise sustainable administration and worth creation. Leveraging the assets and benefits of Fosun’s world industrial ecosystem, Fosun endeavours to create a constructive influence on sustainable improvement and constantly create a greater world.